ProQR Therapeutics
PRQR
51 hedge funds and large institutions have $299M invested in ProQR Therapeutics in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 15 closing their positions.
139% more capital invested
Capital invested by funds: $125M → $299M (+$174M)
133% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 9
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
47% more call options, than puts
Call options by funds: $22K | Put options by funds: $15K
13% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 15
5.34% more ownership
Funds ownership: 55.73% → 61.07% (+5.3%)
2% more funds holding
Funds holding: 50 → 51 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$37.3M |
| 2 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$8.5M |
| 3 |
RI
RTW Investments
New York
|
+$8.4M |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$6.64M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.59M |
| 2 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
-$1.44M |
| 3 |
State Street
Boston,
Massachusetts
|
-$873K |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$857K |
| 5 |
AA
ALPS Advisors
Denver,
Colorado
|
-$446K |
PRQR Hedge Fund Activity: Q4 2019 in Review
51 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q4 2019, worth a combined $299M — up 139% from $125M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new PRQR positions and 15 closed out — a net gain of 2 holders — while 21 added to existing stakes and 9 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $37.3M. The largest seller was BlackRock, cutting an estimated $2.59M.
- 51 institutional investors held ProQR Therapeutics (PRQR) as of Q4 2019, up from 50 in Q3 2019.
- Funds reported $299M of ProQR Therapeutics stock for Q4 2019, up 139% quarter-over-quarter.
- 17 funds opened new ProQR Therapeutics positions in Q4 2019 and 15 closed out, a net change of +2 holders.
- The largest ProQR Therapeutics buyer in Q4 2019 was Wellington Management Group, an estimated $37.3M added.
- The largest ProQR Therapeutics seller in Q4 2019 was BlackRock, an estimated $2.59M sold.
Based on aggregated 13F filings for Q4 2019.